O papel dos hormônios leptina e grelina na gênese da obesidade
Palabras clave:
hipotálamo, leptina, metabolismo, obesidade, tecido adiposoResumen
A prevalência da obesidade está aumentando e estudos prospectivos mostram que, em 2025, o Brasil será o quinto país do mundo a apresentar problemas de obesidade em sua população. A etiologia da obesidade não é de fácil identificação, uma vez que a mesma é caracterizada como uma doença multifatorial, ou seja, diversos fatores estão envolvidos em sua gênese, incluindo fatores genéticos, psicológicos, metabólicos e ambientais. Pesquisas recentes na área de metabolismo mostram que o adipócito é capaz de sintetizar várias substâncias e, diferentemente do que se supunha anteriormente, o tecido adiposo não é apenas um sítio de armazenamento de triglicérides, é hoje considerado um órgão endócrino. Dentre as diversas substâncias sintetizadas pelo adipócito, destacam-se a adiponectina, a angiotensina e a leptina. A leptina é um petídeo que desempenha importante papel na regulação da ingestão alimentar e no gasto energético, gerando um aumento na queima de energia e diminuindo a ingestão alimentar. Além dos avanços no estudo da célula adiposa, um novo hormôrnio relacionado ao metabolismo foi descoberto recentemente, a grelina. A grelina é um peptídeo produzido nas células do estômago, e está diretamente envolvida na regulação do balanço energético a curto prazo. Assim, este artigo abordará o papel da leptina e da grelina no controle do peso corporal e as limitações que ainda existem para tratar a obesidade em humanos.
Citas
Bouchard C. Atividade física e obesidade. São Paulo: Manole; 2000.
Damaso A. Etiologia da obesidade. Rio de Janeiro: Medsi; 2003.
Nobrega FJ. Distúrbios da nutrição. Rio de Janeiro: Revinter; 1998.
Bartness TJ, Bamshad M. Innervation of mammalian white adipose tissue: implications for the regulation of total body fat. Am J Physiol. 1998; 275(44):R1399-R411.
Pénicaud L, Cousin B, Leloup C, Lorsignol A, Casteilla L. The autonomic nervous system, adipose tissue plasticity, and energy balance. Nutrition. 2000; 16(10):903-8.
Saleh J, Sniderman AD, Cianflone K. Regulation of plasma fatty acid metabolism. Clin Chim Acta. 1999; 286(1-2):163-80.
Ahima RS, Flier, JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metabolism. 2000; 11(8):327-32.
Reseland JE, Anderssen SA, Solvoll K, Hjermann I, Urdal P, Holme I, et al. Effect of long-term changes in diet and exercise on plasma leptin concentrations. Am J Clin Nutr. 2001; 73(2): 240-5.
Sinha MK, Sturis J, Ohannesian J, Magosin S, Stephens T, Heiman ML, et al. Ultradian oscillations of leptin secretion in humans. Biochem Biophys Res Commun. 1996; 228(3):733-8.
Maurigeri D, Bonanno MR, Speciale S, Santangelo A, Lentini A, Russo MS, et al. The leptin, a new hormone of adipose tissue: clinical findings and perspectives in geriatric. Arch Gerontol Geriatr. 2002; 34(1):47-54.
Friedmann J M, Halaas JL. Leptin and the regulation of body weight in mammals. Nature. 1998; 395(22):763-70.
Sandoval DA, Davis SN. Leptin: metabolic control and regulation. J Diab Compl. 2003; 17(2): 108-13.
Considini RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum immunoreactive leptin concentrations in normal- -weight and obese humans. N Engl J Med. 1996; 334(5):292-5.
Maffei MJ, Haalas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, et al. Leptin levels in humans and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med. 1995; 11(1):1155-61.
Leyva F, Godsland IF, Ghatei M, Proudler AJ, Aldis S, Walton C, et al. Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterio Thromb Vasc Biol. 1998; 18(6):928-33.
Adami GF, Civalleri D, Cella F, Marinari G, Camerine G, Papadia F, et al. Relationship of serum leptin to clinical and anthropometric findings in obese patients. Obesity Surgery. 2002; 12(5):623-7.
Vierhapper H, Heinze G, Nowotny P, Bieglmayer C. Leptin and the control of obesity. Metabolism. 2003; 52(3):379-81.
Kalra SP, Bagnasco M, Otukonyong EE, Dube MG, Kalra PS. Rhythmic, reciprocal ghrelin and leptin signaling: new insight in the development of obesity. Regul Pept. 2003; 111(1-3):1-11.
Lee DM, Leinung MC, Rozhavskaya-Arena M, Grasso P. Leptin and the treatment of obesity: its current status. Eur J Pharmacol. 2002; 440:129-39.
Kojima M, Hosoda H, Date Y. Ghrelin is a growth- -hormone-releasing acylated peptide from stomach. Nature. 1999; 402:656-60.
Hosoda H, Kojima M, Matsuo H, Kangawa K. Purification and characterization of rats des-Gln 14- Ghrelin, a second endogenous ligand for the growth hormone secretagogue receptor. J Biol Chem. 2000; 275(29):910-13.
Rosicka M, Krsek M, Matoulek Z, Jarkovska Z, Marek J, Justova V, et al. Serum ghrelin levels in obese patients: the relationship to serum leptin levels and soluble leptin receptors levels. Physiol Res. 2003; 52(1):61-6.
Kojima M, Hosoda H, Matsuo H, Kangawa K. Ghrelin: discovery of the natural endogenous ligand for the growth-hormone secretagogue receptor. Trends Endocrinol Metabol. 2001; 12(3):118-22.
Bednarek MA, Feigner SD, Pong SS, McKee KK, Hreniuk DL, Silva MV, et al. Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone
secretagogue receptor 1a. J Med Chem. 2000; 43(23):4370-76.
Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of ras and human. Endocrinology. 2000; 141(11):4255-61.
Papotti M, Ghe C, Cassoni P, Catapano F, Deghengi R, Ghigo E, et al. Growth hormone secretagogue binding sites in peripheral human tissues. J Clin Endocrinol Metabol. 2000; 85(10):3803-7.
Gualillo O, Caminos J, Blanco M, Garcia-Caballero T, Kojima M, Kangawa K, et al. Ghrelin, a novel placental-derived hormone. Endocrinology. 2001; 142(2):788-94.
Smith RG, van der Ploeg LH, Howard AD, Feighner SD, Cheng K, Hickey GJ, et al. Peptidomimetic regulation of growth hormone secretion. Endocr Rev. 1997; 18(5):621-45.
Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto A, Harada M, et al. Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metabol. 2000; 85(12):4908-11.
Ghigo E, Arvat E, Giordano R, Broglio F, Gianotti L, Maccario M, et al. Biologic activities of growth hormone secretagogues in humans. Endocrine. 2001; 14(1):87-93.
Pombo M, Pombo CM, Garcia A, Caminos E, Gualillo O, Alvarez CV. Hormonal control of growth hormone secretion. Horm Res. 2001; 55(Suppl 1):11s-6s.
Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Wakabayashi I. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Diabetes. 2001; 50(11):2438-43.
Masuda Y, Tanaka T, Inomata N, Ohnuma N, Tanaka S, Itoh Z, et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun. 2000; 276(3):905-8.
Muccioli G, Broglio F, Valetto MR, Ghé C, Catapano F, Graziani A, et al. Growth hormone-releasing peptides and the cardiovascular system. Ann Endocrinol. 2000; 61(1):27-31.
Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000; 407(6806): 908-13.
Arvat E, Maccario M, Di Vito L, Broglio F, Benso A, Gottero C, et al. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS) in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and
GH-releasing hormone. J Clin Endocrinol Metab. 2001; 86(5):1169-74.
Nagaya N, Kojima M, Uematsu M, Yamagishi M, Hosoda H, Oya H, et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol. 2001; 280(5):R-1483-7.
Cassoni P, Papotti M, Ghe C, Catapano F, Sapino A, Graziani A, et al. Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in humans breast carcinomas and cell lines. J Clin Endocrinol Metab. 2001; 86(4):1738-45.
Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, et al. A role for ghrelin in the central regulation of feeding. Nature. 2001; 409(6817):194-8.
Ukkola O, Poykoo S. Ghrelin, growth and obesity. Ann Med. 2002; 34(2):102-8.
Leidy HJ, Gardner JK, Frye BR, Snook ML, Schuchert MK, Richard EL. Circulating ghrelin is sensitive to changes in body weight during a diet and exercise program in normal weight young women. J Clin Endocrinol Metabol, 2004; 89(6):2659-64.
Salbe AD, Tshop MH, Delparigi A, Venti C, Tataranni PA . Negative relationship between fasting plasma ghrelin concentrations and ad libitum food intake. J Clin Endocrinol Metabol. 2004; 89(6):2951-6.
Erdmann J, Topsch R, Lippl F, Gussmann P, Schusdziarra V. Postprandial response of plasma ghrelin levels to various test meals in relation to food intake, plasma insulin, and glucose. J Clin Endocrinol Metabol. 2004; 89(6):3048-54.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2023 Carla Eduarda Machado ROMERO, Angelina ZANESCO
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
